Capvaxive
Payments companies reported to CMS as associated with Capvaxive. "Associated with" is CMS's wording: it links a payment to a product without saying the money was spent on it.
By year
Payments reported as associated with Capvaxive, per program year, as reported to CMS.
Who makes it
Specialties most often involved
Where the associated payments went, by the receiving clinician's specialty.
Clinicians most associated with Capvaxive
These are the largest totals companies reported as associated with Capvaxive. They are typically speaking or consulting arrangements, which companies must report by law; appearing here is not evidence of anything improper.
| Clinician | Location | Specialty | Associated payments (2023-2025) |
|---|---|---|---|
| Jihad Slim | Newark, NJ | Infectious Disease | $74,810.54 |
| Vincent Hsu | Orlando, FL | Infectious Disease | $72,291.58 |
| Javeed Siddiqui | Roseville, CA | Infectious Disease | $62,761.01 |
| Harish Moorjani | Briarcliff Manor, NY | Infectious Disease | $61,442.21 |
| Donald Middleton | Pittsburgh, PA | Internal Medicine | $58,259.77 |
| Jorge Parada | Maywood, IL | Infectious Disease | $48,394.29 |
| Robert Feldman | Laguna Hills, CA | Geriatric Medicine (Internal Medicine) | $32,158.67 |
| Bradley Wasson | Arlington, TX | Family Medicine | $31,563.56 |
| Kim Erlich | Burlingame, CA | Infectious Disease | $26,671.07 |
| Gregory Poland | Rochester, MN | Internal Medicine | $16,250.00 |
Prescribed Capvaxive?
See what its makers reported for your doctor. Two steps, private, no account.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.